Ratings by Laidlaw (Yale Jen)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/9/2026 | AEON Biopharma, Inc | AEON | New Coverage | Buy (N/A) |
0.24 (0.33) |
37.5% | Details | |
| 8/17/2026 | EyePoint Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2026 | NewcelX AG | NCEL | New Coverage | Buy (N/A) |
4.13 (3.31) |
-19.85% | Details | |
| 4/15/2026 | Kazia Therapeutics | KZIA | New Coverage | Buy (N/A) |
8.99 (11.21) |
24.69% | Details | |
| 4/6/2026 | Soleno Therapeutics Inc. | SLNO | Downgrade | Hold (Buy) |
39.49 (53.01) |
34.24% | Details | |
| 2/12/2026 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Palatin Technologies | PTN | New Coverage | Buy (N/A) |
25.62 (12.57) |
-50.94% | Details | |
| 11/20/2025 | Femasys Inc. | FEMY | New Coverage | Buy (N/A) |
0.72 (2.75) |
281.94% | Details | |
| 11/6/2025 | Evoke Pharma | EVOK | Downgrade | Hold (Buy) |
10.69 (11.00) |
2.9% | Details | |
| 10/22/2025 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2025 | Nasus Pharma Ltd | NSRX | New Coverage | Buy (N/A) |
8.05 (3.35) |
-58.39% | Details | |
| 8/20/2025 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2025 | Senti Biosciences, Inc. | SNTI | New Coverage | Buy (N/A) |
3.39 (0.31) |
-90.86% | Details | |
| 4/17/2025 | icad Inc. | ICAD | Downgrade | Hold (Buy) |
1.93 (3.87) |
100.52% | Details | |
| 4/4/2025 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2025 | Nuvectis Pharma | NVCT | New Coverage | Buy (N/A) |
8.35 (22.81) |
173.17% | Details | |
| 2/10/2025 | Lifeward | LFWD | New Coverage | Buy (N/A) |
1.35 (7.13) |
428.15% | Details | |
| 11/4/2024 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Evoke Pharma | EVOK | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2024 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2024 | Curis | CRIS | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2024 | NLS Pharmaceutics | NLSP | Downgrade | Hold (Buy) |
0.19 (0.76) |
300% | Details | |
| 7/29/2024 | Abivax | ABVX | New Coverage | Buy (N/A) |
11.86 (117.04) |
886.85% | Details | |
| 7/23/2024 | MEI Pharma | MEIP | Downgrade | Hold (Buy) |
2.86 (3.07) |
7.34% | Details | |
| 7/2/2024 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2024 | IN8bio Inc. | INAB | Maintain | Buy (N/A) |
|
Details | ||
| 6/12/2024 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | IN8bio Inc. | INAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | BiomX | PHGE | New Coverage | Buy (N/A) |
0.34 (1.85) |
444.12% | Details | |
| 3/19/2024 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | IN8bio Inc. | INAB | New Coverage | Buy (N/A) |
1.14 (1.12) |
-1.75% | Details | |
| 3/13/2024 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2023 | Cingulate | CING | Downgrade | Hold (Buy) |
2.15 (5.20) |
141.86% | Details | |
| 12/5/2023 | EyePoint Pharmaceuticals, Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/28/2023 | Silo Pharma | SILO | New Coverage | Buy (N/A) |
1.90 (2.19) |
15.26% | Details | |
| 8/15/2023 | Alaunos Therapeutics Inc. | TCRT | Downgrade | Hold (Buy) |
0.39 (1.50) |
284.62% | Details | |
| 6/6/2023 | Bellerophon Therapeutics | BLPH | Downgrade | Hold (Buy) |
7.06 (0.01) |
-99.86% | Details | |
| 5/16/2023 | Viking Therapeutic | VKTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Bellerophon Therapeutics | BLPH | New Coverage | Buy (N/A) |
9.07 (0.01) |
-99.89% | Details | |
| 9/6/2022 | NLS Pharmaceutics | NLSP | New Coverage | Buy (N/A) |
0.51 (0.76) |
49.02% | Details | |
| 6/23/2022 | F-Star Therapeutics Inc. | FSTX | Downgrade | Hold (Buy) |
3.98 (7.12) |
78.89% | Details | |
| 6/6/2022 | Curis | CRIS | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2022 | Evofem Biosciences Inc | EVFM | New Coverage | Buy (N/A) |
0.35 (0.01) |
-97.14% | Details | |
| 5/10/2022 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2022 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2022 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2022 | Cingulate | CING | New Coverage | Buy (N/A) |
2.58 (5.20) |
101.55% | Details | |
| 12/16/2021 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2021 | Taiwan Liposome Co Ltd. | TLC | Downgrade | Hold (Buy) |
5.73 (7.00) |
22.16% | Details | |
| 6/29/2021 | aTyr Pharma | LIFE | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Carpenter Technology | CRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2021 | aTyr Pharma | LIFE | New Coverage | Buy (N/A) |
3.82 (40.50) |
960.21% | Details | |
| 4/6/2021 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2021 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2021 | F-Star Therapeutics Inc. | FSTX | New Coverage | Buy (N/A) |
11.59 (7.12) |
-38.57% | Details | |
| 3/10/2021 | Affimed Therapeutics | AFMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2021 | Soleno Therapeutics Inc. | SLNO | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | Athenex | ATNX | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2020 | Curis | CRIS | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2020 | BioSig Technologies, Inc | BSGM | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2020 | Onconova Therapeutics | ONTX | Downgrade | Hold (Buy) |
1.01 (15.36) |
1420.79% | Details | |
| 7/31/2020 | Opko Health | OPK | Maintain | Buy () |
|
Details | ||
| 7/29/2020 | Curis | CRIS | New Coverage | Buy (N/A) |
1.26 (1.17) |
-7.14% | Details | |
| 2/19/2020 | Molecular Templates | MTEM | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2019 | Soleno Therapeutics Inc. | SLNO | New Coverage | Buy (N/A) |
1.73 (39.49) |
2182.66% | Details | |
| 11/4/2019 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Buy (N/A) |
2.37 (4.36) |
83.97% | Details | |
| 8/9/2019 | Sesen Bio, Inc | SESN | Downgrade | Hold (Buy) |
1.17 (0.63) |
-46.15% | Details | |
| 7/3/2019 | Affimed Therapeutics | AFMD | Maintain | Buy (Buy) |
|
Details | ||
| 5/20/2019 | Hoth Therapeutics | HOTH | New Coverage | Buy (N/A) |
5.50 (1.36) |
-75.27% | Details | |
| 4/1/2019 | ZIOPHARM Oncology | ZIOP | New Coverage | Buy (N/A) |
3.76 (0.87) |
-76.86% | Details | |
| 3/25/2019 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | Ionis Pharmaceuticals | IONS | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2019 | Fennec Pharmaceuticals Inc. | FENC | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2018 | Onconova Therapeutics | ONTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2018 | Molecular Templates | MTEM | New Coverage | Buy (N/A) |
5.42 (0.11) |
-97.97% | Details | |
| 8/31/2018 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details |
